Concepedia

Publication | Closed Access

Rituximab in refractory autoimmune diseases: Brazilian experience with 29 patients (2002-2004).

60

Citations

8

References

2006

Year

Abstract

Rituximab seems to be safe and effective in the treatment of patients with a variety of autoimmune diseases that are refractory to other modalities of treatment.

References

YearCitations

Page 1